Biotech companies have always licensed programs, but never so many from one region in particular.

Partnership strategy has produced great pharma bargains—and left the company exposed.

As large biopharma companies have increasingly turned to China for novel biotech innovation, political calls in the U.S. to ...

Jyong Biotech Ltd. (Nasdaq: MENS) (the 'Company' or 'Jyong Biotech'), a science-driven biotechnology company dedicated to the ...

HONG KONG, May 28 (Reuters) - Small biotech firms "latch onto" AI more quickly than bigger firms, the head of Chinese tech ...

If you’re looking to diversify outside of AI, especially as AI investors look to trim their winners to save up for that ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that it will present data on CTA313, its investigational ...

Hims & Hers Health shares have slumped in 2026 as the telehealth provider moves away from selling compounded GLP-1 medications. As Kevin Warsh steps up to lead the Federal Reserve, the case for ...

Graig Suvannavejh, Managing Director of Equity Research at Mizuho Securities, discusses major ASCO presentations, biotech volatility, cancer breakthroughs and emerging oncology companies to watch.

BTIG initiated research coverage with a buy rating, calling the biotech's experimental hair loss treatment a possible 'GLP-1 ...

BioMarin Pharmaceutical, a San Rafael biotech company known for treating extremely rare diseases, said Wednesday it’s laying off 225 workers, most of whom live and work in California. The cuts come ...

Panda Biotech recently made its India market debut at the Yarns & Fibers Expo in Mumbai.